Remogliflozin etabonate (GSK189075)
Remogliflozin etabonate (GSK189075) is an orally active, selective and low-affinity inhibitor of sodium glucose cotransporter (SGLT2) with Ki of 1950 nM, 2140 nM, 43100 nM, 8570 nM for hSGLT2, rSGLT2, hSGLT1, rSGLT1, respectively. Remogliflozin etabonate exhibits antidiabetic efficacy in rodent models.
| Trivial name | N/A |
| Catalog Number | S0993 |
| Molecular Formula | C26H38N2O9 |
| CAS# | 442201-24-3 |
| SMILES | CCOC(=O)OCC1C(C(C(C(O1)OC2=NN(C(=C2CC3=CC=C(C=C3)OC(C)C)C)C(C)C)O)O)O |
| Size | 25mg |
| Supplier Page | http://www.selleckchem.com/products/remogliflozin-etabonate.html |
| Additional Information | https://file.selleck.cn/downloads/struct/s0993-remogliflozin-etabonate-chemical-structure.gif |